Skip to content
Telehealth Graded
State guide

Louisiana Medicaid and GLP-1s

The takeaway

Louisiana Medicaid wants a signed treatment agreement before Wegovy or Zepbound, sets the Wegovy floor at age 45, and asks about bariatric surgery.

Reading the state documents

Louisiana asks for something no other state on this site asks for: a treatment agreement, completed and filed with the request, before anything is dispensed. On top of that the Wegovy pathway starts at 45 rather than 18, and if the BMI is 35 or higher the state wants to see that you were at least assessed for surgery first.

2
documents cited
8
sourced facts
2
primary sources

What changed, and what the document says

  1. The paperwork before the drug

    Conditions apply

    A separate signed document, named in the criteria, submitted alongside the authorization request.

    “For initiation of therapy requests, the Tirzepatide (Zepbound®) Treatment Agreement for Louisiana Medicaid Recipients must be completed as instructed and submitted with the request form.”

    Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026

  2. Wegovy starts at 45

    Conditions apply

    Not 18, and not the label's floor. Forty-five is the age this pathway opens at.

    “The recipient is 45 years of age or older on the date of the request; AND”

    Louisiana Department of Health, Louisiana Medicaid — Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026

  3. A BMI window, not a floor

    Conditions apply

    Between 27 and 35 you qualify on the number alone. Above 35 the state adds a step.

    “The recipient has a documented Body Mass Index (BMI) of ≥ 27 kg/m2 and < 35 kg/m2;”

    Louisiana Department of Health, Louisiana Medicaid — Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026

  4. Surgery gets assessed first

    Conditions apply

    The heavier you are, the more Louisiana wants to know you looked at an operation before a prescription.

    “The recipient has a documented BMI ≥ 35 kg/m2, and documentation of evaluation or referral for bariatric surgery is provided with the request”

    Louisiana Department of Health, Louisiana Medicaid — Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026

  5. Zepbound's threshold

    Conditions apply

    A sleep study, a number, and a twelve-month recency window on the test itself.

    “The patient has an established diagnosis of moderate to severe obstructive sleep apnea (OSA) with an apnea-hypopnea index (AHI) of ≥ 15 on polysomnography (PSG) within the previous 12 months (Documentation is required showing test results with corresponding date); AND”

    Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026

  6. Non-adherence to CPAP counts in the patient's favor

    Context

    An unusual clause: not sticking with the machine is one of the two ways to satisfy this criterion.

    “The recipient has a history of non-adherence to PAP therapy; AND”

    Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026

  7. Two chances at 5 percent

    Conditions apply

    Miss the target once and you get three months with a written reason. Miss it twice and the criteria stop.

    “For weight loss < 5%, do not approve.”

    Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026

  8. Six months to prove it

    Conditions apply

    That's the initiation window on the sleep-apnea route before anything is reassessed.

    “Duration of approval for initiation of therapy: 6 months”

    Louisiana Department of Health, Louisiana Medicaid — Policy created June 2025, implementation date January 2026

Telehealth in Louisiana

  • CCaveat
    $1,299
    a month, medication only
    brand Ozempic (semaglutide), cash price
    Additional fees not verified.
    Price details
    • No separate monthly fee was found in the pages reviewed. Other charges may apply.
    • Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to.
    See Gala Health pricing (opens in a new tab)

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve Louisiana?

Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.

14 of those lists name Louisiana: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Trimi, Rx.com, Mojoon, Peak Wellness, Allara Health, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Source dates below are the dates printed on the documents.

  • Louisiana Medicaid — Tirzepatide (Zepbound®) — Louisiana Department of Health, Louisiana Medicaid. the single row of the "Revision / Date" and "Implementation Date" table on the last page — the URL path reads 9_26_25 and the filename reads 06052025, and neither is this document's date: Policy created June 2025, implementation date January 2026.
  • Louisiana Medicaid — Semaglutide (Wegovy®) — Louisiana Department of Health, Louisiana Medicaid. the whole "Revision / Date" and "Implementation Date" table on the last page, reproduced as the list it is: Policy created April 2024, implemented July 2024; revised September 2024, implemented October 2024; revised November 2025, implemented March 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.